Literature DB >> 28677004

Morphologic analysis with computed tomography may help differentiate fat-poor angiomyolipoma from renal cell carcinoma: a retrospective study with 602 patients.

Yong Hee Kim1, Kyunghwa Han1, Young Taik Oh1, Dae Chul Jung1, Nam Hoon Cho2, Sung Yoon Park3.   

Abstract

PURPOSE: To assess whether morphologic analysis using computed tomography (CT) could differentiate between fat-poor angiomyolipoma (fpAML) and renal cell carcinoma (RCC).
METHODS: A total of 602 patients with a histologically confirmed fpAML (n = 49) or RCC (n = 553) were evaluated. All renal lesions were less than 4 cm in size and had no gross fat on contrast-enhanced CT. For morphologic analysis, overflowing beer sign and angular interface were evaluated. Overflowing beer sign was defined as contact length between bulging-out portion of a mass and the adjacent renal capsule of 3 mm or greater. Angular interface was defined as the angle of parenchymal portion of a mass of 90° or less. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy were assessed. Multivariate analysis was conducted to determine which variable is predictive of fpAML.
RESULTS: Sensitivity, specificity, PPV, NPV, and accuracy were 61.2% (30/49), 97.1% (537/553), 65.2% (30/46), 96.6% (537/556), and 94.2% (567/602) with overflowing beer sign, while they were 55.1% (27/49), 81.9% (453/553), 21.3% (27/127), 95.4% (453/475), and 79.7% (480/602) with angular interface for fpAML, respectively. Both CT variables were predictive of fpAML (overflowing beer sign, odds ratio = 132.881, p < 0.001; angular interface, odds ratio = 5.766, p = 0.010). The multivariate model with CT variables showed good performance for predicting fpAML (AUC, 0.871 with angular interface, 0.943 with overflowing beer sign, and 0.949 with both).
CONCLUSION: Morphologic analysis with contrast-enhanced CT may be useful for differentiating fpAML from RCC. Overflowing beer sign has the potential as an imaging biomarker for fpAML.

Entities:  

Keywords:  Angiomyolipoma; Computed tomography; Fat-poor; Overflowing beer sign; Renal cell carcinoma

Mesh:

Substances:

Year:  2018        PMID: 28677004     DOI: 10.1007/s00261-017-1244-y

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  5 in total

1.  Role of computed tomography features in the differential diagnosis of chromophobe renal cell carcinoma from oncocytoma and angiomyolipoma without visible fat.

Authors:  Cuiping Zhou; Xiaohua Ban; Jianxun Lv; Lin Cheng; Jianmin Xu; Xinping Shen
Journal:  Quant Imaging Med Surg       Date:  2022-04

2.  A Non-Invasive Scoring System to Differential Diagnosis of Clear Cell Renal Cell Carcinoma (ccRCC) From Renal Angiomyolipoma Without Visible Fat (RAML-wvf) Based on CT Features.

Authors:  Xiao-Jie Wang; Bai-Qiang Qu; Jia-Ping Zhou; Qiao-Mei Zhou; Yuan-Fei Lu; Yao Pan; Jian-Xia Xu; You-You Miu; Hong-Qing Wang; Ri-Sheng Yu
Journal:  Front Oncol       Date:  2021-04-23       Impact factor: 6.244

Review 3.  The Risks of Renal Angiomyolipoma: Reviewing the Evidence.

Authors:  Raouf M Seyam; Waleed K Alkhudair; Said A Kattan; Mohamed F Alotaibi; Hassan M Alzahrani; Waleed M Altaweel
Journal:  J Kidney Cancer VHL       Date:  2017-10-16

4.  Review of Value of CT Texture Analysis and Machine Learning in Differentiating Fat-Poor Renal Angiomyolipoma from Renal Cell Carcinoma.

Authors:  Yuhan Zhang; Xu Li; Yang Lv; Xinquan Gu
Journal:  Tomography       Date:  2020-12

5.  Differential diagnosis and prognosis of small renal masses: association with collateral vessels detected using contrast-enhanced computed tomography.

Authors:  Masato Yanagi; Tomonari Kiriyama; Jun Akatsuka; Yuki Endo; Hayato Takeda; Akifumi Katsu; Yuichiro Honda; Kyota Suzuki; Yoshihiro Nishikawa; Shunsuke Ikuma; Hikaru Mikami; Yuka Toyama; Go Kimura; Yukihiro Kondo
Journal:  BMC Cancer       Date:  2022-08-05       Impact factor: 4.638

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.